DK265587A - Farmaceutisk praeparat, der indeholder et polypeptid, til gastro-intestinal resorption - Google Patents

Farmaceutisk praeparat, der indeholder et polypeptid, til gastro-intestinal resorption

Info

Publication number
DK265587A
DK265587A DK265587A DK265587A DK265587A DK 265587 A DK265587 A DK 265587A DK 265587 A DK265587 A DK 265587A DK 265587 A DK265587 A DK 265587A DK 265587 A DK265587 A DK 265587A
Authority
DK
Denmark
Prior art keywords
gastro
polypeptide
pharmaceutical preparation
preparation containing
intestinal resorption
Prior art date
Application number
DK265587A
Other languages
Danish (da)
English (en)
Other versions
DK265587D0 (da
Inventor
Jacky Vonderscher
Joachim Franz
Michel Steiger
Karl Hornung
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2138/86A external-priority patent/CH667994A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK265587D0 publication Critical patent/DK265587D0/da
Publication of DK265587A publication Critical patent/DK265587A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK265587A 1986-05-27 1987-05-25 Farmaceutisk praeparat, der indeholder et polypeptid, til gastro-intestinal resorption DK265587A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH214486 1986-05-27
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.

Publications (2)

Publication Number Publication Date
DK265587D0 DK265587D0 (da) 1987-05-25
DK265587A true DK265587A (da) 1987-11-28

Family

ID=25689611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK265587A DK265587A (da) 1986-05-27 1987-05-25 Farmaceutisk praeparat, der indeholder et polypeptid, til gastro-intestinal resorption

Country Status (21)

Country Link
US (1) US5393738A (fr)
KR (1) KR870010870A (fr)
AU (1) AU601740B2 (fr)
BE (1) BE1000722A4 (fr)
CA (1) CA1299495C (fr)
DE (1) DE3716437A1 (fr)
DK (1) DK265587A (fr)
ES (1) ES2008126A6 (fr)
FI (1) FI872313A (fr)
FR (2) FR2599254B1 (fr)
GB (1) GB2190838B (fr)
GR (1) GR870820B (fr)
HU (1) HU198626B (fr)
IL (1) IL82645A0 (fr)
LU (1) LU86901A1 (fr)
MY (1) MY101233A (fr)
NL (1) NL8701143A (fr)
NO (1) NO171484C (fr)
NZ (1) NZ220418A (fr)
SE (1) SE8702188L (fr)
WO (1) WO1987007149A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
FR2668933B1 (fr) * 1990-06-15 1995-05-05 Sandoz Sa Composition pharmaceutique a base de somatostatine.
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
DE19949897A1 (de) * 1999-10-15 2001-04-19 Rainer Rogasch Formkörper und Verfahren zu dessen Herstellung
EP1118333A1 (fr) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions avec une biodisponibilité orale augmentée
ES2383303T3 (es) 2005-11-10 2012-06-20 Chemi S.P.A. Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
ES2629131T3 (es) 2008-09-17 2017-08-07 Chiasma Inc. Composiciones farmacéuticas y métodos de suministro relacionados.
AU2015201581B2 (en) * 2008-09-17 2017-03-09 Amryt Endo, Inc. Pharmaceutical Compositions and Related Methods of Delivery
CA2784120A1 (fr) 2009-12-16 2011-07-14 Nod Pharmaceuticals, Inc. Compositions et procedes d'administration de medicaments par voie orale
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
EP3229824A4 (fr) 2014-12-10 2018-07-11 Chiasma Inc. Octréotide destiné à être administré par voie orale en association avec d'autres agents thérapeutiques
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1062898A (en) * 1912-12-09 1913-05-27 Fred Drew Automobile.
GB1062898A (en) * 1963-06-14 1967-03-22 Evans Medical Ltd Pharmaceutical compositions containing protamines
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4041155A (en) * 1974-10-29 1977-08-09 American Home Products Corporation Long acting somatostatin composition
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
CA1098444A (fr) * 1975-05-26 1981-03-31 Leo Geller Preparations de peptide a action prolongee
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
US4093574A (en) * 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4087390A (en) * 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
DK144731C (da) * 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4230695A (en) * 1976-08-02 1980-10-28 Vitose Corporation Enhanced protein assimilation with fructose
JPS5920647B2 (ja) * 1976-10-01 1984-05-15 武田薬品工業株式会社 注射剤
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
CA1107273A (fr) * 1978-05-19 1981-08-18 Chester A. Meyers Analogues de la somatostatine ayant un residu tryptophyl substitue en position 8
EP0029579B1 (fr) * 1979-11-27 1983-02-16 Sandoz Ag Polypeptides, procédés pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
JPS57146722A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS57146723A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS57118509A (en) * 1981-01-14 1982-07-23 Toyo Jozo Co Ltd Novel preparation of high absorbability
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
SE460638B (sv) * 1981-01-14 1989-11-06 Toyo Jozo Kk Suppositoriepreparat med foerbaettrad absorptionsegenskap
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
WO1982003773A1 (fr) * 1981-04-27 1982-11-11 Baxter Travenol Lab Solution de dialyse contenant du glucose, des acides amines et de l'insuline
EP0083619A1 (fr) * 1981-07-17 1983-07-20 Nordisk Insulinlaboratorium Preparation therapeutique d'insuline aqueuse stable et son procede de preparation
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
WO1985002118A1 (fr) * 1983-11-21 1985-05-23 Regents Of The University Of Minnesota Melange tamponne de polyol-hormone destine a etre utilise dans l'administration parenterale chronique d'hormones
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides

Also Published As

Publication number Publication date
FI872313A (fi) 1987-11-28
DK265587D0 (da) 1987-05-25
SE8702188D0 (sv) 1987-05-25
ES2008126A6 (es) 1989-07-16
AU7336487A (en) 1987-12-03
NO171484C (no) 1993-03-24
GB8712193D0 (en) 1987-06-24
NO171484B (no) 1992-12-14
HU198626B (en) 1989-11-28
LU86901A1 (fr) 1987-12-16
FR2630916B1 (fr) 1993-10-22
KR870010870A (ko) 1987-12-18
GB2190838A (en) 1987-12-02
NO872174D0 (no) 1987-05-25
CA1299495C (fr) 1992-04-28
US5393738A (en) 1995-02-28
FR2599254B1 (fr) 1989-12-01
HUT43956A (en) 1988-01-28
MY101233A (en) 1991-08-17
FI872313A0 (fi) 1987-05-25
WO1987007149A1 (fr) 1987-12-03
GR870820B (en) 1987-09-25
SE8702188L (sv) 1987-11-28
AU601740B2 (en) 1990-09-20
FR2630916A1 (fr) 1989-11-10
NL8701143A (nl) 1987-12-16
FR2599254A1 (fr) 1987-12-04
BE1000722A4 (fr) 1989-03-21
IL82645A0 (en) 1987-11-30
GB2190838B (en) 1990-12-12
NZ220418A (en) 1990-07-26
DE3716437A1 (de) 1987-12-03
NO872174L (no) 1987-11-30

Similar Documents

Publication Publication Date Title
DK265587A (da) Farmaceutisk praeparat, der indeholder et polypeptid, til gastro-intestinal resorption
DE3772269D1 (de) Kapsel mit verzoegerter freisetzung.
NO843592L (no) Fremgangsmaate for fremstilling av et polypeptid
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
DE3786767T3 (de) Neues Polypeptid.
NL194828B (nl) Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten.
DE68912777D1 (de) Insulin-analoge.
ATA257190A (de) Virales polypeptid
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK271482A (da) Fremgangsmaade til fremstilling af et polypeptid
DK586185D0 (da) Carbostyrilforbindelser, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK181586A (da) 2,5-diaryltetrahydrofuran, farmaceutisk praeparat indeholdendeen saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse
DK503388D0 (da) Oxadiazolyl-azabicycloheptan, farmaceutisk praeparat indeholdende en saadan forbindelse, fremgangsmaade til fremstiling deraf, mellemprodukt og fremgangsmaade til fremstilling deraf
DK707788A (da) 2,5-diaryltetrahydrofuranforbindelse, praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse
DK551287A (da) Polypeptid
DK354389D0 (da) Polypeptid
DK250090D0 (da) Alkylphyosphonoserin, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK160991C (da) 5,14-dihydrobenzoe5,6aaisoindolooe2,1-baaisoquinolin-8,13-dionderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
NO832148L (no) Fremgangsmaate for fremstilling av et farmakologisk aktivt polypeptid
DK680787D0 (da) Farmaceutisk praeparat indeholdende en pyranoquinolinforbindelse
DK5785A (da) Tricycliske forbindelser, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK403585D0 (da) Histargin-beslaegtede forbindelser, en fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
NO872586D0 (no) Fremgangsmaate for fremstilling av et rekombinant, konjugert protein.
DK289684A (da) Carboxylsyreamidforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
ES540922A0 (es) Un procedimiento para preparar peptidos ciclicos

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment